CTX001 for transfusion-dependent beta-thalassemia (TDT): safety and efficacy results from the ongoing CLIMB THAL-111 study of autologous CRISPR-CAS9-modified CD34(+) hematopoietic stem and progenitor cells (HSPCs)

Corbacioglu, Selim and Locatelli, F. and Ailinca-Luchian, S. and Bobruff, Y. and Cappellini, M. D. and Domm, J. and Foell, J. and de la Fuente, J. and Handgretinger, R. and Ho, T. W. and Hobbs, W. and Kattamis, A. and Li, A. and Lu, Y. and Palomino, L. and Shanbhag, N. and Sharma, A. and Sheth, S. and Sripakdeevong, P. and Wall, D. and Frangoul, H. (2021) CTX001 for transfusion-dependent beta-thalassemia (TDT): safety and efficacy results from the ongoing CLIMB THAL-111 study of autologous CRISPR-CAS9-modified CD34(+) hematopoietic stem and progenitor cells (HSPCs). In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation
Depositing User:	Petra Gürster
Date Deposited:	01 Dec 2022 09:59
Last Modified:	01 Dec 2022 09:59
URI:	https://pred.uni-regensburg.de/id/eprint/47694

Actions (login required)

View Item